PharmaShots | Incisive News in 3 Shots

Subscribe Now

Metastaic Breast Cancer

Oncology Venture Signs an Exclusive Option Agreement to In-License Commercialization Rights for R-Pharm's Ixempra (ixabepilone) in EU

Oncology Venture Signs an Exclusive Option Agreement to In-License Commercialization Rights for R-Pharm's Ixempra (ixabepilone) in...

April 5, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us